We are pleased to report that Humble Juice Co. submitted its PMTA to the U.S. Food and Drug Administration on Thursday September 3, 2020. As a producer of e-liquid products, Humble is required to go through the PMTA process to remain on the market. The goal of our submission is to receive marketing orders from FDA for our suite of e-liquid products, allowing us to continue providing our retailers, distributors and consumers with high-quality, flavor-filled e-juice for the long-term. Our team dedicated significant time and resources into preparing our PMTA submission. We are confident in our submission and look forward to the next step in the PMTA journey: the formal acceptance of our application by FDA.